]>
IRCT20231007059642N1 IRCT 2023-10-22 Esfahan University of Medical Sciences Investigating the effect of electromagnetism in reducing knee osteoarthritis symptoms Investigating the effectiveness of electromagnetic therapy on improving the symptoms of second and third degree knee osteoarthritis 2023-10-23 anticipated 60 Complete https://irct.ir/trial/73026 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: A simple randomization method is used. Sampling will be done by the method of alternating blocks of 2 in such a way that we will have 10 blocks of 3 and each block will contain 3 letters from the letters A and B, including AAB-ABA-BBA-BAB and..... (two groups of 30 Each patient is randomly given a card, the cards are in sealed envelopes, and the technician takes the envelopes in order and delivers them to the patients, Blinding description: Random Allocation version 2 software will be used. Sampling will be done by the method of 2 permutation blocks in such a way that we will have 10 blocks of 4 and each block contains 4 letters from letters A and B including AABB-ABAB-BBAA-BABA and..... (two groups of 40) one card for each patient randomly It is given that the cards are in sealed envelopes and the technician takes the envelopes in order and delivers them to the patients. Due to the nature of the study, it is not possible to blind the patients. The person who collects the data does not know whether the data belongs to group A or group B. The person who analyzes the data does not know whether he belongs to group A or group B. N/A Knee osteoarthritis. Intervention 1: Intervention group: In this group, drug treatment with 1 tablet of meloxicam 15mg once a day for 18 days and exercise therapy 3 times a day for 18 days, each for 20 seconds and 3 times each time.Sports include the following:Stretching of quadriceps and calf muscle, strengthening of quadriceps and hamesteringIn addition to drug therapy and exercise, the group is performed using the magno 915G device, made in Iran, located in the physical medicine and rehabilitation department of Amin Hospital. The number of PEMF sessions is 8 sessions, 3 times a week. The patient is in a supine position. The back (SUPINE) is placed on the bed. Then the entire knee area will be placed under the electromagnet device. The total treatment time per session is 30 minutes. Intervention 2: Control group:In this group, drug treatment with 1 tablet of meloxicam 15mg once a day for 18 days and exercise therapy 3 times a day for 18 days, each for 20 seconds and 3 times each time.Sports include the following:Stretching of quadriceps and calf muscle, strengthening of quadriceps and hamesteringIn this group, the magnet device is turned off for the patient. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information
public Saeideh Safinataj
Unit 5, Hafez Building, 4th dead end on the right, 28 Yavar Alley,Barazande Street
Isfahan Iran (Islamic Republic of) 8193967748 +98 913 347 5411 saeide.safi@gmail.com Esfahan University of Medical Sciences scientific Saeideh Safinataj
Unit 5,hafez building,Right side of the 4th deadend,Yavar 28 alley,Barazandeh street
Esfahan Iran (Islamic Republic of) 8193967748 +98 913 347 5411 saeide.safi@gmail.com Esfahan University of Medical Sciences Iran (Islamic Republic of) Primary diagnosis of grade 2 and 3 OA based on ACR criteria, including radiological evidence, clinical examination and history Age ≥40 years The presence of dry knee symptoms and frequent daily pain since 6 months ago Symptomatic illness from at least 6 months ago Presence of pain with VAS ≥3 criteria 40 years 70 years Both Intra-articular drug administration in the last 6 months Systemic treatment with corticosteroids or physical therapy in the last 6 weeks Cartilaginous consumption in the last 6 weeks Back radicular pains Knee pain caused by malignant, autoimmune and inflammatory pathology or caused by knee deformities such as genovarus and genovalgus etc. Patients who have a history of knee surgery Lack of cooperation and difficulty in referring and following the intervention process pregnancy Metal implant like heart pacemaker M17 Osteoarthritis of knee Treatment - Devices Treatment - Devices Intervention group: In this group, drug treatment with 1 tablet of meloxicam 15mg once a day for 18 days and exercise therapy 3 times a day for 18 days, each for 20 seconds and 3 times each time.Sports include the following:Stretching of quadriceps and calf muscle, strengthening of quadriceps and hamesteringIn addition to drug therapy and exercise, the group is performed using the magno 915G device, made in Iran, located in the physical medicine and rehabilitation department of Amin Hospital. The number of PEMF sessions is 8 sessions, 3 times a week. The patient is in a supine position. The back (SUPINE) is placed on the bed. Then the entire knee area will be placed under the electromagnet device. The total treatment time per session is 30 minutes. Control group:In this group, drug treatment with 1 tablet of meloxicam 15mg once a day for 18 days and exercise therapy 3 times a day for 18 days, each for 20 seconds and 3 times each time.Sports include the following:Stretching of quadriceps and calf muscle, strengthening of quadriceps and hamesteringIn this group, the magnet device is turned off for the patient. Symptoms of knee osteoarthritis. Timepoint: before, immediately and 6 weeks and 3 months after the end of the treatment. Method of measurement: Visual Analogue Scale and Western Ontario and McMaster Universities Osteoarthritis Index scale. Average pain intensity. Timepoint: Before, immediately and 6 weeks and 3 months after the end of the treatment. Method of measurement: Visual Analogue Scale. Physical performance. Timepoint: Before, immediately and 6 weeks and 3 months after the end of the treatment. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index. Joint dryness. Timepoint: Before, immediately and 6 weeks and 3 months after the end of the treatment. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index. Range of motion. Timepoint: Before, immediately and 6 weeks and 3 months after the end of the treatment. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index. Esfahan University of Medical Sciences Approved 2023-10-03 Ethical Committee of Isfahan University of Medical Sciences, Faculty of Medicine Unit 5, Hafez Building, 4th dead end on the right, 28 Yavar Alley, Barazandeh Street Isfahan Isfehan Iran (Islamic Republic of)